Loading...

NDRA ENDRA LIFE SCIENCES INC Capital Structure Changes 8-K Filing

NDR

NDR

ENDRA LIFE SCIENCES INC

(NDRA)

2025 8-K

Summary

Summary

Stock Offering Agreement

Digital Asset Launch

Technical Correction

Fundraising Announcement

Cryptocurrency Treasury Str...

Equity Offerings

Investor Meetings

Failure to Maintain Listing...

Financial Statements

Financial Results

Nasdaq Compliance

Financial Results

Stock Split Approval

Nasdaq Compliance Extension

CEO Resignation

Management Changes

Agreement for Stock and War...

Financial Results Announcement

Results of Operations and F...

Financial Results Announcement

Financial Results Announcement

Financial Results and FDA A...

Annual Meeting Results

Meeting Adjournment

Financial Results Announcement

Underwriting Agreement

Financial Results

Financial Results Announcement

External Links:

On July 9, 2025, ENDRA Life Sciences Inc. filed a prospectus for a public offering of common stock and warrants, including preliminary financial results for the quarter ended June 30, 2025.

AI Assistant

ENDRA LIFE SCIENCES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.